Successful treatment of a patient with nephrotic syndrome associated with chronic lymphocytic leukemia

Internal Medicine

Volumn 39, Issue 3, 2000, Pages 256-259

  Takahashi, Fumihiko ^a   Ogawa, Yuji ^a   Hasebe, Naoyuki ^a   Natori, Syunsuke ^a   Tokusashi, Yoshihiko ^a   Miyokawa, Naoyuki ^a   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Glomerulonephritis; Malignancy

Indexed keywords

BENCE JONES PROTEIN; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMMUNOGLOBULIN KAPPA CHAIN; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; MALE; NEPHROTIC SYNDROME; PROTEINURIA;

EID: 0034128477     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.256     Document Type: Article

References (14)

1. Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int 30: 465-473, 1986.
2. Touchard G, Preud'homme JL, Aucouturier P, et al. Nephrotic syndrome associated with chronic lymphocytic leukemia: an immunological and pathological study. Clin Nephrol 31: 107-116, 1989.
3. Moulin B, Ronco PM, Mougenot B, Francois A, Fillastre JP, Mignon F. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int 42: 127-135, 1992.
4. Seney FD Jr, Federgreen WR, Stein H, Kashgarian M. A review of nephrotic syndrome associated with chronic lymphocytic leukemia. Arch Inlern Med 146: 137-141, 1986.
5. Eisterer W, Neyer U, Hilbe W, et al. Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia. Nephron 72: 468-471, 1996.
6. Halimi JM, Lavabre-Bertrand T, Béraud JJ, Canaud B. Nephrotic syndrome associated with chronic lymphocytic leukemia resistant to immunosuppressive drugs: Remission obtained by splenectomy. Clin Nephrol 45: 273-276, 1996.
7. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198-206, 1981.
8. Ganeval D, Noël LH, Preud'homme JL, Droz D, Grünfeld JP. Light-chain deposition disease: its relation with AL-type amyloidosis. Kidney Int 26: 1-9, 1984.
9. Alpers CE. Glomerulopathies of dysproteinemias, abnormal immunoglobulin deposition, and lymphoproliferative disorders. Curr Opin Nephrol Hypertens 3: 349-355, 1994.
10. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 333: 1052-1057, 1995.
11. Imbs JL, Schmidt M, Giesen EM, Schwartz J. Effect of captopril on intrarenal blood flow. Am J Med 76: 53-57 (Suppl 5B), 1984.
12. Kon V, Fogo A, Ichikawa I. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int 44: 545-550, 1993.
13. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993.
14. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334: 939-945, 1996.